PICO Portalanswers from OpenAlex & ORCID
Bruce Strober
ResearcherPublications, citations & collaboration network
Bruce Strober is a researcher indexed in PICO Portal from OpenAlex & ORCID.
How many works does Bruce Strober have?
PICO Portalindexed works
Bruce Strober has 477 works in the PICO Portal index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Bruce Strober have?
PICO Portalcitation count
Bruce Strober has 19,920 citations in the OpenAlex counts PICO Portal stores.
What is the h-index of Bruce Strober?
PICO Portalh-index
Bruce Strober has an h-index of 66 in OpenAlex.
What is the i10-index of Bruce Strober?
PICO Portali10-index
Bruce Strober has an i10-index of 188 in OpenAlex.
What is the ORCID of Bruce Strober?
PICO Portalorcid
The ORCID for Bruce Strober is on the source record.
What is the OpenAlex record for Bruce Strober?
PICO Portalopenalex
The OpenAlex for Bruce Strober is on the source record.
What are the most-cited papers on Bruce Strober?
PICO Portalmost cited works
Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with biologics
Alan Menter, Bruce Strober, Daniel H. Kaplan, Darío Kivelevitch, Elizabeth Farley Prater, Benjamin K. Stoff, April W. Armstrong, Cody Connor, Kelly M. Cordoro, Dawn Marie R. Davis, Boni E. Elewski, Joel M. Gelfand, Kenneth B. Gordon, Alice B. Gottlieb, Arthur Kavanaugh, Matthew Kiselica, Neil J. Korman, Daniela Kroshinsky, Mark Lebwohl, Craig L. Leonardi, Jason Lichten, Henry W. Lim, Nehal N. Mehta, Amy S. Paller, Sylvia L. Parra, Arun L. Pathy, Reena Rupani, Michael Siegel, Emily Wong, Jashin J. Wu, Vidhya Hariharan, Craig A. Elmets
Adalimumab therapy for moderate to severe psoriasis: A randomized, controlled phase III trial
Alan Menter, Stephen K. Tyring, Kenneth B. Gordon, Alexa B. Kimball, Craig L. Leonardi, Richard G. Langley, Bruce Strober, Martin Kaul, Yihua Gu, Martin M. Okun, Kim Papp
Comparison of Ustekinumab and Etanercept for Moderate-to-Severe Psoriasis
C.E.M. Griffiths, Bruce Strober, Peter van de Kerkhof, Vincent Ho, Roseanne Fidelus-Gort, Newman Yeilding, Cynthia Guzzo, Yichuan Xia, Bei Zhou, Shu Li, Lisa T. Dooley, Neil Goldstein, Alan Menter
Phase 3 Studies Comparing Brodalumab with Ustekinumab in Psoriasis
Mark Lebwohl, Bruce Strober, Alan Menter, Kenneth B. Gordon, Jolanta Węgłowska, L. Puig, Kim Papp, Lynda Spelman, Darryl Toth, Francisco A. Kerdel, April W. Armstrong, Georg Stingl, Alexa B. Kimball, H. Bachelez, Jashin J. Wu, Jeffrey Crowley, Richard G. Langley, Tomasz Blicharski, C. Paul, J.‐P. Lacour, Stephen K. Tyring, Leon Kircik, Sergio Chimenti, Kristina Callis Duffin, Jerry Bagel, John Koo, Gary Aras, Joanne Li, Wenjie Song, Cassandra E. Milmont, Yifei Shi, Ngozi Erondu, Paul Klekotka, Brian L. Kotzin, Ajay Nirula
Efficacy and safety of risankizumab in moderate-to-severe plaque psoriasis (UltIMMa-1 and UltIMMa-2): results from two double-blind, randomised, placebo-controlled and ustekinumab-controlled phase 3 trials
Kenneth B. Gordon, Bruce Strober, Mark Lebwohl, Matthias Augustin, Andrew Blauvelt, Yves Poulin, Kim Papp, Howard Sofen, L. Puig, Peter Foley, Mamitaro Ohtsuki, Mary Flack, Ziqian Geng, Yihua Gu, Joaquin Valdes, Elizabeth H. Thompson, H. Bachelez